Login / Signup

Obesity and chronic kidney disease: A current review.

Saira NawazRajkumar ChinnaduraiSaif Al-ChalabiPhilip EvansPhilip A KalraAkheel A SyedSmeeta Sinha
Published in: Obesity science & practice (2022)
Obesity is a risk factor for the onset and progression of CKD and should be recognized as a potential target for a preventative public health approach to reduce CKD rates within the general population. Future research should focus on the use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors in patients with CKD and obesity due to their multi-faceted actions on major outcomes.
Keyphrases